Article
The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
Alimentary pharmacology & therapeutics - 1 Aug 2015
Holmes J A, Congiu M, Bonanzinga S, Sandhu M K, Kia Y H, Bell S J, Nguyen T, Iser D M, Visvanathan K, Sievert W, Bowden D S, Desmond P V, Thompson A J
Abstract excerpt
BACKGROUND: The biological mechanism underlying the association between IFNL4/IFNL3 polymorphism and peginterferon/ribavirin (PR) response in HCV-1 is thought to involve differential intrahepatic interferon-stimulated gene expression. HCV-3 is more sensitive to PR, but there are no studies of the association between IFNL4 polymorphism, PR treatment response and liver interferon-stimulated gene expression in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
